IMVT earnings
Immunovant (IMVT) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
IMVT earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q1 2027 | Aug 6, 2026 | -0.75 | -0.63 | -19.26% | $7.09M |
| Q4 2026 | May 20, 2026 | -0.73 | -0.59 | -23.31% | – |
| Q3 2026 | Feb 6, 2026 | -0.61 | -0.72 | 15.28% | – |
| Q2 2026 | Nov 10, 2025 | -0.73 | -0.72 | -1.39% | – |
| Q1 2026 | Aug 11, 2025 | -0.60 | -0.69 | 13.04% | – |
| Q4 2025 | May 29, 2025 | -0.64 | -0.71 | 10.27% | – |
| Q3 2025 | Feb 6, 2025 | -0.76 | -0.73 | -4.11% | – |
| Q2 2025 | Nov 6, 2024 | -0.74 | -0.61 | -21.31% | – |
| Q1 2025 | Aug 6, 2024 | -0.60 | -0.53 | -13.21% | – |
| Q4 2024 | May 29, 2024 | -0.52 | -0.43 | -20.93% | – |
| Q3 2024 | Feb 12, 2024 | -0.36 | -0.43 | 16.28% | – |
| Q2 2024 | Nov 9, 2023 | -0.45 | -0.47 | 4.26% | – |
| Aug 10, 2023 | -0.57 | -0.45 | -26.67% | – | |
| May 22, 2023 | -0.46 | -0.43 | -6.98% | – | |
| Feb 3, 2023 | -0.49 | -0.39 | -25.64% | – | |
| Nov 4, 2022 | -0.41 | -0.39 | -5.13% | – | |
| Aug 5, 2022 | -0.35 | -0.40 | 12.50% | – | |
| Jun 8, 2022 | -0.41 | -0.38 | -7.89% | – | |
| Feb 4, 2022 | -0.36 | -0.33 | -9.09% | – | |
| Nov 5, 2021 | -0.35 | -0.28 | -25.00% | – |
- IMVT reports next on Nov 9, 2026, with EPS of -0.75 expected.
- IMVT beat EPS estimates in 10 of its last 27 reports.
Updated 2026-11-03 00:01 UTC